Early determinants of atherosclerosis in paediatric systemic lupus erythematosus

被引:0
|
作者
Boros, C. A. [1 ,6 ,9 ]
Bradley, T. J. [2 ,9 ]
Cheung, M. M. H. [2 ,9 ]
Bargman, J. M. [5 ,7 ]
Russell, J. L. [2 ,9 ]
McCrindle, B. W. [2 ,9 ]
Adeli, K. [3 ]
Hamilton, J. [4 ,9 ]
Silverman, E. D. [1 ,6 ,8 ,9 ]
机构
[1] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Clin Biochem, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada
[5] Toronto Gen Hosp, Div Nephrol, Toronto, ON, Canada
[6] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[9] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
关键词
vascular testing; cardiovascular risk factors; lipids; insulin resistance; LOW-DENSITY-LIPOPROTEIN; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; MYOCARDIAL-PERFUSION; YOUNG-ADULTS; WOMEN; CHILDREN; DISEASE; HOMOCYSTEINE; PROGRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess traditional and non-traditional cardiovascular risk factors and to determine the prevalence and correlates of early vascular markers of atherosclerosis in paediatric systemic lupus erythematosus (pSLE). Methods Fifty-four adolescents with pSLE had cardiovascular risk factor assessment, disease activity and vascular testing including carotid intima-media thickness (CIMT), flow-mediated dilatation (FMD), arterial stiffness measures, and myocardial perfusion studies. Results The traditional risk factors of hypertension, elevated triglycerides, apolipoprotein B, haemoglobin AI c and insulin levels and non-traditional risk factors of elevated homocysteine and fibrinogen were present (all p<0.001). Some arterial stiffness measures, central pulse wave velocity and characteristic impedance were elevated (p<0.001), but CIMT, FMD and myocardial perfusion were normal. Cumulative prednisone dose correlated with total cholesterol (r=0.5790, p<0.001) and elevated LDL-C (r=0.4488, p=0.0012). Hydroxychloroquine treatment correlated negatively with total cholesterol (r=-0.4867, p=0.0002), LDL-C (r=-0.4805, p=0.0002) and apolipoprotein B (r=-0.4443, p=0.0011). In multivariate analysis LDL-C correlated with cumulative prednisone dose and negatively with hydroxychloroquine treatment (R-2=0.40, p<0.001). Conclusions An increased burden of traditional and non-traditional risk factors and early evidence of insulin resistance and increased central arterial stiffness were present in paediatric SLE. Disease-specific and therapy-related factors are likely modifying these cardiovascular risk profiles warranting prospective longitudinal studies.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 50 条
  • [1] Atherosclerosis in systemic lupus erythematosus
    Croca, Sara
    Rahman, Anisur
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2017, 31 (03): : 364 - 372
  • [2] Atherosclerosis in systemic lupus erythematosus
    Mezalek, Zoubida Tazi
    Harmouche, Hicham
    Ammouri, Wafaa
    Maamar, Mouna
    Adnaoui, Mohamed
    Cacoub, Patrice
    PRESSE MEDICALE, 2014, 43 (10): : 1034 - 1047
  • [3] Atherosclerosis in systemic lupus erythematosus
    Sherer, Yaniv
    Zinger, Hasia
    Shoenfeld, Yehuda
    AUTOIMMUNITY, 2010, 43 (01) : 98 - 102
  • [4] Atherosclerosis in Systemic Lupus Erythematosus
    Tobin, Rachel
    Patel, Nidhi
    Tobb, Kardie
    Weber, Brittany
    Mehta, Puja K.
    Isiadinso, Ijeoma
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (11) : 819 - 827
  • [5] Atherosclerosis in Systemic Lupus Erythematosus
    Stojan, George
    Petri, Michelle
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (03) : 255 - 262
  • [6] Lupus nephritis as an independent risk factor for carotid atherosclerosis in patients with systemic lupus erythematosus
    Wang, Yujiao
    Guo, Simin
    Shi, Yirui
    Wei, Xiaoquan
    Chen, Weiwei
    Zhang, Yaqi
    Yuan, Xinran
    Sun, Lingyun
    CLINICAL RHEUMATOLOGY, 2025, : 1927 - 1937
  • [7] Risk Factors in the Progression of Subclinical Atherosclerosis in Women With Systemic Lupus Erythematosus
    Lertratanakul, Apinya
    Wu, Peggy
    Dyer, Alan R.
    Kondos, George
    Edmundowicz, Daniel
    Carr, James
    Ramsey-Goldman, Rosalind
    ARTHRITIS CARE & RESEARCH, 2014, 66 (08) : 1177 - 1185
  • [8] Metabolic syndrome in Iranian patients with systemic lupus erythematosus and its determinants
    Fatemi, Alimohammad
    Ghanbarian, Azadeh
    Sayedbonakdar, Zahra
    Kazemi, Mehdi
    Smiley, Abbas
    CLINICAL RHEUMATOLOGY, 2018, 37 (06) : 1521 - 1528
  • [9] Atherosclerosis and systemic lupus erythematosus
    Urowitz M.
    Gladman D.
    Bruce I.
    Current Rheumatology Reports, 2000, 2 (1) : 19 - 23
  • [10] Renal manifestations of paediatric systemic lupus erythematosus
    Dowsett, Thomas
    Oni, Louise
    CURRENT OPINION IN PEDIATRICS, 2022, 34 (02) : 203 - 208